Experimental studies in humans

Publications:

Wilson JA, Johnston D, Penston J, Wormsley KG.
Gastric inhibitory effects of CM57755. A new histamine H2 receptor antagonist.
European Journal of Clinical Pharmacology 1986;30(1):33-6.

Penston J, Johnston DA, Wilson JA, Wormsley KG.
Inhibition of nocturnal gastric secretion by trimoprostil, a synthetic prostanoid.
Current Medical Research and Opinion 1986;10(3):145-9.

Penston JG, Johnston DA, Wormsley KG.
Trimoprostil decreases acid disappearance from the human stomach.
Current Medical Research and Opinion 1986;10(5):308-12.

Wilson JA, Johnston DA, Penston J, Wormsley KG.
Inhibition of human gastric secretion by ICI 162,846--a new histamine H2-receptor antagonist.
British Journal of Clinical Pharmacology 1986 Jun;21(6):685-9.

Penston JG, Johnston DA, Wormsley KG.
The effects of rioprostil on gastric emptying and intragastric acidity.
Hepatogastroenterology. 1986 Jun;33(3):120-2.

Hamilton I, Boyd EJ, Jacyna MR, Penston JG, Soutar JS, Bouchier IA.
Pancreatic function and enzyme synthesis rates in mild chronic pancreatitis.
Scandinavian Journal of Gastroenterology 1986 Jun;21(5):542-6

Johnston DA, Jankowski J, Penston JG, Wormsley KG.
Inhibition of nocturnal gastric secretion is not necessary for ulcer healing.
European Journal of Gastroenterology and Hepatology 1989; 1; 187-191.

Corbett ME, Boyd EJ, Penston JG, Wormsley KG, Watt PW, Rennie MJ.
Pentagastrin increases pepsin secretion without increasing its fractional synthetic rate.
American Journal of Physiology 1995 Sep;269(3 Pt 1):E418-25.

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.


Get Flash Player